 |
|
 |
 |
 |
Apoptosis Pathway : DNA-PK
 | | | DNA-PK Antibodies
|
|
|
|
|
| Anti-DNA-PK (Ab-1) (2015-2134) Rabbit pAb |
IB, IF, IP, PS |
horse, human, mouse, rat, Xenopus |
PC127 |
| Anti-DNA-PK (Ab-2) Mouse mAb (18-2) |
FS, IB, IF, IP, NT, PS |
human |
NA57 |
|
| | | DNA-PK Inhibitors
| | | | Additional Information | | | | | | | | |
| Protein : PRKDC
| | | | Connectivity | 264 |
|---|
| Notes | May phosporylate AKT/PKB on Ser473 |
|---|
| Hugo ID | 9413 |
|---|
| Name | PRKDC |
|---|
| Description | protein kinase, DNA-activated, catalytic polypeptide |
|---|
| URN | urn:agi-llid:5591 |
| | | | GO Cellular Component | nucleus |
| | | | Cell Localization | Nucleus |
|---|
| | Cytoplasm |
| | | | GO Biological Process | DNA repair |
|---|
| | apoptosis |
|---|
| | double-strand break repair |
|---|
| | DNA recombination |
|---|
| | protein modification |
| | | | Alias | Prkdc |
|---|
| | scid |
|---|
| | slip |
|---|
| | DNAPK |
|---|
| | DNPK1 |
|---|
| | HYRC1 |
|---|
| | XRCC7 |
|---|
| | DNA-PK |
|---|
| | DNAPDcs |
|---|
| | protein kinase, DNA activated, catalytic polypeptide |
|---|
| | severe combined immunodeficiency |
|---|
| | DNA-PKcs |
|---|
| | HYRC |
|---|
| | p350 |
|---|
| | PRKD |
|---|
| | protein kinase, DNA-activated, catalytic polypeptide |
|---|
| | hyper-radiosensitivity of murine scid mutation, complementing 1 |
|---|
| | PRKD_HUMAN |
|---|
| | DNA-dependent protein kinase catalytic subunit DNPK1 |
|---|
| | DNA- PKcs |
|---|
| | DNA-dependent protein kinase catalytic subunit |
|---|
| | DNPK I |
|---|
| | hyper-radiosensitivity of murine scid mutation, complementing I |
|---|
| | HYRC I |
|---|
| | similar to DNA-dependent protein kinase |
|---|
| | hyper-radiosensitivity of murine scid mutation, complementing |
|---|
| | PDK2? |
| | | | Organism | Mus musculus |
|---|
| | Human |
| | | | Pathway | AKT signaling |
|---|
| | DNA Repair |
|---|
| | PL AKT signaling |
|---|
| | 'GSK3 50' plus |
| | | | Group | Kinases |
|---|
| | nucleic acid binding |
|
 |
 |
|
|